Please assess the completion status of the following clinical trial:

Trial Title: An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* children and adolescents (aged 6 to less than 18 years) with Familial Hypercholesterolaemia~* Patients aged between 6 and less than 10 years of age must not be taking a statin medicine~Exclusion Criteria:~* History of muscle or sensitivity reactions to any statin medicines~* Current active liver disease or dysfunction (except a confirmed diagnosis of Gilbert's disease)

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).